Robotic-Assisted Coronary Artery Bypass Grafting vs. Percutaneous Coronary Intervention Strategies for Ostial Left Anterior Descending
Anatolian Journal of Cardiology, cilt.29, sa.6, ss.300-311, 2025 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 6
- Basım Tarihi: 2025
- Doi Numarası: 10.14744/anatoljcardiol.2025.5050
- Dergi Adı: Anatolian Journal of Cardiology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.300-311
- Anahtar Kelimeler: Death, left main bifurcation, major adverse cardiovascular, cerebral events, robotic-assisted coronary bypass grafting, percutaneous coronary intervention
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: The comparison of outcomes of robotic-assisted coronary artery bypass grafting (RA-CABG) vs. stenting techniques (ostial or crossover stenting) for ostial left anterior descending (LAD) artery lesions is still lacking. This retrospective study sought to determine the mid-term outcomes of RA-CABG, crossover stenting (CS), and ostial stent implantation (OSI) in patients with ostial LAD disease. Methods: All cases were divided into 3 groups as follows: RA-CABG (group 1) (n = 157), CS (group 2) (n = 104), and OSI (group 3) (n = 178). The primary endpoint was defined as the major adverse cardiac and cerebral events (MACCE), which included cardiac death, tar-get vessel myocardial infarction, target vessel revascularization (TVR), stroke, and stent thrombosis or symptomatic graft occlusion during follow-up. This is the first investigation comparing mid-term outcomes of RA-CABG, CS, and OSI as revascularization options for ostial LAD lesions. Results: A total of 439 consecutive individuals [male: 341 (77.6%), mean age: 59.58 ± 9.35 years] with ostial LAD disease were included in this study. The rates of MACCE (P = .020 for groups 3 vs. 1; P = .011 for groups 3 vs. 2) and clinically driven TVR (15.7 vs. 4.5%, P = .001 for groups 3 vs. 1; 15.7 vs. 5.8%, P = .014 for groups 3 vs. 2) were notably higher in group 3 than the others. The mid-term MACCE [(adjusted hazard ratio = 2.129 [95% confidence interval: 1.360-3.334], P = .001)] in the overall population significantly differed between group 3 and the others. Conclusion: The findings of the study suggest that OSI for ostial LAD lesions was associ-ated with higher mid-term MACCE and TVR rates than revascularization with RA-CABG or CS.